Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 16/20 | 0.63 |
| ▸ | FNTB | P49356 | 16/20 | 0.63 |
| ▸ | PGGT1B | P53609 | 4/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3499107 | 0.92 | FNTA (0.56) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL3500578 | 0.92 | FNTA (0.56) | FNTAFNTBPGGT1BCYP3A4 | |
| Hydrochloric Acid SCHEMBL7669730 | 0.92 | FNTA (0.55) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL6170234 | 0.92 | FNTA (0.55) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL3498778 | 0.92 | FNTA (0.56) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL5722593 | 0.91 | CYP3A4 (0.57) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL6162996 | 0.91 | FNTA (0.62) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL6165529 | 0.90 | FNTA (0.78) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL13529451 | 0.89 | FNTA (0.67) | FNTAFNTBPGGT1BCYP3A4 | |
| SCHEMBL3555644 | 0.89 | FNTA (0.66) | FNTAFNTBPGGT1BCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1107962-B1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PROD INC (US) | 2005-02-23 | — | — | EP | claimed |
| US-6495564-B1 | SUCH AS 3-(6-((4-CHLORO-PHENYL)-HYDROXY-(3-METHYL-3H-IMIDAZOL-4-YL)-METHYL)-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLIN-4-YL)-BENZALDEHYDE O-METHYL-OXIME; INHIBITING ABNORMAL CELL GROWTH | PFIZER INC. | 2002-12-17 | — | — | US | claimed |
| EP-1107962-A1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | Pfizer Products Inc. (US) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012498-A1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2000-03-09 | — | — | WO | claimed |
| EP-1107962-B1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PROD INC (US) | 2005-02-23 | — | — | EP | disclosed |
| US-6495564-B1 | SUCH AS 3-(6-((4-CHLORO-PHENYL)-HYDROXY-(3-METHYL-3H-IMIDAZOL-4-YL)-METHYL)-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLIN-4-YL)-BENZALDEHYDE O-METHYL-OXIME; INHIBITING ABNORMAL CELL GROWTH | PFIZER INC. | 2002-12-17 | — | — | US | disclosed |
| EP-1107962-A1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | Pfizer Products Inc. (US) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000012498-A1 | QUINOLIN-2-ONE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2000-03-09 | — | — | WO | disclosed |